Ludo Reynders joins Premier Research Group
This article was originally published in Clinica
Contract research organisation Premier Research Group has appointed Ludo Reynders CEO. Dr Reynders was previously CEO of AAIPharma, which he transformed from a pharma company specialising in pain into a drug development services firm. Before this, he worked for Quintiles Translational Corporation for 16 years in several positions including managing director of pharmabio development and CEO of Quintiles Development Services. He was also employed by Bristol Myers for seven years. Philadelphia, Pennsylvania-based Premier Research carries out trials in the analgesia, oncology, neuroscience and cardiovascular fields, and also has experience in medical device and paediatric research.